Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,820 Million (Small Cap)
177.00
NA
0.19%
-0.23
10.10%
15.14
Revenue and Profits:
Net Sales:
74 Million
(Quarterly Results - Sep 2025)
Net Profit:
1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-24.7%
0%
-24.7%
6 Months
-39.25%
0%
-39.25%
1 Year
-1.57%
0%
-1.57%
2 Years
111.86%
0%
111.86%
3 Years
38.5%
0%
38.5%
4 Years
10.38%
0%
10.38%
5 Years
65.56%
0%
65.56%
Shanghai Jiaoda Onlly Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.42%
EBIT Growth (5y)
122.47%
EBIT to Interest (avg)
-3.46
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
0.85
Tax Ratio
6.05%
Dividend Payout Ratio
30.03%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.96%
ROE (avg)
5.10%
Valuation key factors
Factor
Value
P/E Ratio
177
Industry P/E
Price to Book Value
19.74
EV to EBIT
120.60
EV to EBITDA
57.78
EV to Capital Employed
25.08
EV to Sales
20.00
PEG Ratio
0.32
Dividend Yield
0.15%
ROCE (Latest)
20.79%
ROE (Latest)
11.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
73.70
77.40
-4.78%
Operating Profit (PBDIT) excl Other Income
2.00
21.50
-90.70%
Interest
2.00
2.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.90
10.10
-91.09%
Operating Profit Margin (Excl OI)
26.90%
101.10%
-7.42%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is -4.78% vs 6.91% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -91.09% vs 283.64% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
323.70
295.30
9.62%
Operating Profit (PBDIT) excl Other Income
69.30
30.30
128.71%
Interest
10.30
13.80
-25.36%
Exceptional Items
37.00
-4.10
1,002.44%
Consolidate Net Profit
35.60
-31.90
211.60%
Operating Profit Margin (Excl OI)
51.10%
-62.40%
11.35%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 9.62% vs -21.36% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 211.60% vs 93.56% in Dec 2023
About Shanghai Jiaoda Onlly Co., Ltd. 
Shanghai Jiaoda Onlly Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






